“Staying safe” – a narrative review of falls prevention in people with Parkinson’s – “PDSAFE”
EditorParkinson’s disease demonstrates a spectrum of motor and non-motor symptoms. Falling is common and disabling.
Science
3 hot topics from the world’s largest dementia research conference
Aoife Kiely, Research Communications Officer, shares her highlights from the AAIC with insights from Dr Doug Brown, Chief Policy and Research Officer.
Across Time and Space: Machine Learning Reveals Paths to Dementia
Developing computational algorithms & machine-learning techniques, to transform cross-sectional imaging data to a longitudinal picture and reconstruct the sequence of disease progression.
Alzheimer’s Society launches 2019 Dementia Research Leaders awards
In the run up to the Alzheimer’s Society Annual Conference 2019 in May, the ‘Dementia Research Leaders awards’ are now open for nominations.
An Antimicrobial Approach to Treating Alzheimer’s?
Brush, Floss, Take a Protease Inhibitor? Do periodontal bacteria cause some cases of Alzheimer’s disease? Scientists at one start-up think so.
An introduction to overviews of reviews: planning a relevant research question and objective for an overview
Overviews of systematic reviews are a relatively new approach to synthesising evidence, and research methods and associated guidance are developing.
Analysing the market for care homes for older people using Care Quality Commission and other data
In this webinar Professor Ruth Hancock analyses the market for care homes for older people using Care Quality Commission and other data.
Are Tauopathies Caused by Neuronal and Glial Senescence?
In AD, tau tangles correlate closely with neurodegeneration, but how they work their mischief remains unclear… or does it?
Bad Synergy—Together, Vascular Problems and Aβ Hasten Memory Slippage
People at risk for future cardiovascular events also face greater odds of developing memory problems, according to a May 23 study in JAMA Neurology.
Bump in the Road or Disaster? BACE Inhibitors Worsen Cognition
Merck shook the field with news that people on verubecestat scored worse than those on placebo – find out more in this post from AlzForum
Cancer Treatment Takes Aim at Tauopathy
3 years ago Michal Schwartz at the Weizmann Institute of Science, deployed an immune-boosting approach pioneered for cancer in a mouse model of Alzheimer’s disease. How has this progressed?